SEC Form 4 · accession 0001140361-17-029123
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Gold
Director
Period of report
Jul 25, 2017
Accepted (ET)
Jul 28, 2017 · 3:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 25, 2017 | M | 14,000 | $15.75 | A | 66,037 | D | |
| Common Stock | Jul 25, 2017 | F | 12,879 | $17.12 | D | 53,158 | D | |
| Common StockF1 | Jul 26, 2017 | A | 7,976 | $0.00 | A | 61,134 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $15.75 | Jul 25, 2017 | M | 14,000 | D | Aug 3, 2010 | Aug 3, 2017 | Common Stock | 14,000 | 0 | D |
Explanation of responses
- F1The acquisition of 7,976 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 7,976 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/26/2018.
- F2Options for 33 1/3% of the total number of shares each became exercisable on 8/3/2011, 8/3/2012 and 8/3/2013.